References
- Stevens DA. Fungal infections in AIDS patients. Brit J Clin Pract 1990; 44: 11–22.
- Nassar F, Brummer E, Stevens DA. Different components in human serum inhibit multiplication of Cryptococcus neoformans and enhance fluconazole activity. Antimicrob Agents Chemother 1995; 39: 2490–2493.
- Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685.
- Igel HJ, Bolande RP. Humoral defense mechanisms in cryptococ-cosis: substances in normal human serum, saliva and cerebrospinal fluid affecting the growth of Cryptococcus neoformans. J Infect Dis 1966; 116: 75–83.
- Fishman RA. Cerebrospinal Fluid in Diseases of the Nervous System, 2nd edn. Philadelphia: W.B. Saunders Co., 1992; 204.
- Grover DD, Brummer E, Stevens DA. Study of the role of iron in the anticryptococcal activity of human serum and fluconazole. Mycopathology 1996; 133: 71–77.
- Dromer F, Denning DW, Stevens DA, Noble A, Hamilton JR. Anti-Cryptococcal neoformans antibodies during cryptococcosis in patients with acquired immunodeficiency syndrome. Serodiag Immunother Infect Dis 1995; 7: 181–188.
- Chandler FW. Pathology of the mycoses in patients with the acquired immunodeficiency syndrome. In: McGinnis MR, ed. Current Topics in Medical Mycology, Vol. 1. New York: Springer-Verlag, 1985; 1–23.